What is a Design History File (DHF) and why it should generate itself

The Design History File is the formal record that your device was developed under design controls. It is not a marketing document, a summary, or a retrospective narrative—it is the contemporaneous evidence that every decision made during development was intentional, traceable, and defensible. For any FDA-regulated medical device manufacturer, the DHF is not optional. Under 21 CFR 820.30(j), FDA requires that each manufacturer establish and maintain a DHF for each type of device. That file must contain or reference the records necessary to demonstrate that the design was developed in accordance with the approved design plan and the requirements of the regulation.

The consequence of that requirement is significant. If your engineering team made good decisions but did not document them contemporaneously, you cannot reconstruct the DHF from memory and be confident it will hold up to an FDA inspection or support a submission review. The DHF is not a test you prepare for—it is a record you maintain continuously throughout development.

What a complete DHF contains

21 CFR 820.30 structures design controls around a specific sequence of activities, and the DHF must contain evidence of each one. Working through the regulation in order gives you the skeleton of what every DHF must address.

Design and development planning is where you document what you intended to build, how you planned to build it, and who was responsible for each phase. The plan must be updated as development proceeds—a static document that does not reflect the actual development trajectory is a documentation failure waiting to become an inspection finding.

Design inputs are the physical and performance requirements that must be satisfied for the device to meet its intended use. These are not marketing requirements—they are engineering requirements with measurable acceptance criteria. User needs get translated into design inputs, and that translation must itself be documented. A common gap in DHFs is a set of well-articulated user needs and a set of well-defined design outputs, with no documented rationale for how one became the other.

Design outputs are the results of each design phase—drawings, specifications, software, manufacturing procedures, and any other deliverable that defines the device. Design outputs must be expressed in terms that allow adequate evaluation of conformance to design input requirements. If your output cannot be measured against your input, your design control process has a structural defect.

Design reviews are formal documented evaluations of design results. Each review must include at least one individual who does not have direct responsibility for the design stage being reviewed. The DHF must contain meeting records, attendees, findings, and any action items—and those action items must be closed before the record is complete.

Design verification confirms that design outputs meet design inputs. This is the testing, analysis, inspection, and demonstration work that answers the question: does the device do what we specified? Verification protocols, results, and conclusions all belong in the DHF.

Design validation confirms that the device meets user needs—that what was specified was the right specification. Validation typically involves testing under actual or simulated use conditions, often with end users. Validation must confirm that the device works for its intended use in the hands of its intended users—not just that it performs to a specification written by engineers.

Design transfer documents the translation of the verified and validated design into production specifications. The DHF must contain evidence that the device that will be manufactured at scale is the same device that was validated.

Design changes must each be documented, evaluated for impact on form, fit, and function, verified and validated as appropriate, and approved before implementation. Every change is a DHF entry, and every change must carry forward the traceability thread that connects it to affected inputs, outputs, risk controls, and verification records.

Why manual DHF compilation is a structural risk

In most medical device companies today, the DHF is compiled—meaning engineers finish their work in one set of tools, and a separate effort is required to collect, organize, and format that work into a document package that meets regulatory expectations. That compilation happens in the weeks or months before a submission, often under deadline pressure, and it is performed by people who were not always present when the decisions were made.

The structural problem with compilation is that it introduces a gap between what was decided and what was recorded. Memory is reconstructive, not reproductive. When a design engineer is asked months later why a particular material was selected, they can often recall the conclusion but not the evaluation that led to it—the alternatives that were considered and rejected, the test data that differentiated them, the risk analysis that weighted the tradeoffs. The DHF is supposed to capture that evaluation. If it only captures the conclusion, it is incomplete.

FDA reviewers understand this dynamic. A DHF that reads as a coherent narrative written at the end of a project—rather than a collection of contemporaneous records created throughout development—raises questions about whether design controls were actually followed or merely documented after the fact. Deficiency letters citing incomplete design control records are among the most common causes of 510(k) review delays. For PMA submissions, the stakes are higher: FDA reviewers for high-risk devices examine DHF completeness and contemporaneity with significant scrutiny.

There is also the change management problem. Every time a design change is made late in development—a common occurrence in any real engineering program—the DHF must be updated to reflect the change and its impact. If the DHF exists as a collection of static documents in a shared drive, identifying which records need updating requires manual cross-referencing across a fragmented set of files. Changes get made. Records do not always follow.

Why the DHF should be a natural output of engineering

The premise behind MANKAIND's engineering intelligence platform is that the DHF should not be compiled—it should generate itself as a direct output of the engineering process. This is not a semantic distinction. It reflects a fundamentally different architecture for how design decisions are captured and connected.

When engineers make design decisions inside the platform, those decisions are structured with their regulatory context from the moment they are made. A design input is not just a line of text—it is an object that knows which user needs it addresses, which design outputs will need to satisfy it, and which verification activities will be required to confirm it. A design change is not just a revision to a file—it is a change event that understands its downstream dependencies and surfaces what needs re-evaluation.

That structured approach means the DHF is not a document that gets written at the end. It is a living record that exists and evolves throughout development—accurate at every moment because it is the direct output of the engineering decisions made in the platform, not a reconstruction of them. By the time a submission is being prepared, the DHF is substantially complete. The work of submission preparation shifts from compilation to review—confirming the record is complete, not building it from scratch.

For engineering teams working on complex or high-risk devices, this shift is not a convenience—it is a competitive advantage. Programs that do not spend months in retroactive documentation move faster, launch sooner, and arrive at submission with a cleaner record. The DHF is where regulatory strategy and engineering discipline meet. The platform that connects them determines whether that meeting is productive or painful.